Survival with stage 5 kidney failure ranges from months to decades, depending almost entirely on the treatment path chosen, the person’s age, and what other health conditions they carry. Without any form of dialysis or transplant, median survival in studies of older adults falls roughly between 6 and 23 months. On dialysis, one-year survival sits around 80% for non-diabetic patients overall, though it drops sharply with age and comorbidities. A successful kidney transplant offers the longest outlook by a wide margin. The honest answer is that no single number captures life expectancy at this stage, because the variables that shape it are enormous.
Survival Without Dialysis or Transplant
Some people with stage 5 kidney failure, particularly older adults with serious coexisting illnesses, choose not to start dialysis. This path is sometimes called conservative kidney management. A systematic review of these patients found median survival of at least six months, with individual studies reporting anywhere from about 6 to 23 months.1PubMed Central. Conservative Management of End-Stage Renal Disease without Dialysis: A Systematic Review That range is wide because the populations studied varied. A younger person in otherwise good health would almost certainly do better than these numbers suggest, but younger patients rarely choose conservative management, so the data skews heavily toward elderly people with multiple health problems.
A UK study comparing conservative management with dialysis in elderly patients found that median survival from entry into stage 5 was about 21 months for those managed conservatively, versus 67 months for those on dialysis. That looks like a clear win for dialysis until you zoom in on the oldest and sickest patients. Among those over 75 with high comorbidity scores and diabetes, the survival advantage of dialysis shrank to roughly four months and was not statistically significant.2PubMed Central. Survival of elderly patients with stage 5 CKD: comparison of conservative management and renal replacement therapy In other words, dialysis added years of life for relatively healthy older adults, but for the frailest patients it may not meaningfully extend survival at all.
A 2025 Cochrane review looking across 23 studies and more than 24,000 participants found that conservative management was associated with higher all-cause mortality compared to dialysis, but the certainty of that evidence was rated very low, largely because the studies were observational and highly variable.3PubMed Central. Conservative kidney management versus dialysis for stage 5 chronic kidney disease in older people The takeaway is not that dialysis fails to help, but that the benefit is far less clear-cut for elderly people with serious comorbidities than many families assume.
How Long People Live on Dialysis
For the broader population on dialysis, survival depends heavily on age and whether diabetes caused the kidney failure. Data from the U.S. Medicare program found that one-year survival on dialysis was about 80% for non-diabetic patients and about 73% for those whose kidney failure stemmed from diabetes. Among the youngest patients starting dialysis (ages 15 to 24), one-year survival exceeded 95%. But for those over 85, it dropped to roughly 53%.4PubMed. Mortality rates among dialysis patients in Medicare’s End-Stage Renal Disease Program Those numbers are from an older dataset, and dialysis technology has improved since then, but the age gradient remains a consistent finding across more recent research as well.
The leading causes of death in dialysis patients tell part of the story. Heart-related problems are a major killer, but infection is also a leading cause, and voluntary withdrawal from dialysis accounts for a substantial share of deaths, especially among older patients. One study found that infections caused more than 36% of all deaths, withdrawal from dialysis accounted for about 21%, and cardiac causes made up roughly 14%.5PubMed. Mortality in dialysis patients: analysis of the causes of death Another analysis confirmed that men had a 22% higher risk of death than women on dialysis, driven largely by higher rates of heart attack and cancer deaths.6Journal of the American Society of Nephrology. Causes of death in dialysis patients: racial and gender differences
Peritoneal Dialysis Versus Hemodialysis
Dialysis comes in two main forms: hemodialysis, which filters blood through a machine typically at a clinic three times a week, and peritoneal dialysis, which uses the lining of the abdomen and can often be done at home. People sometimes wonder whether one is safer than the other, and the research gives a complicated answer that depends on timing and patient characteristics.
A large propensity-matched study found that peritoneal dialysis patients had slightly better cumulative survival than hemodialysis patients overall, with one-year survival of about 86% versus 81%. But that advantage faded over time. By three and four years, the difference was small and no longer statistically significant.7PubMed Central. Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients The survival benefit of peritoneal dialysis was strongest among younger patients, those without diabetes, and those without cardiovascular disease. A separate analysis of the first two years of dialysis found that peritoneal dialysis was associated with roughly half the mortality risk of hemodialysis during that window, even after accounting for patients who switched modalities or received transplants.8PubMed Central. Comparing mortality of peritoneal and hemodialysis patients in the first 2 years of dialysis therapy: a marginal structural model analysis
But the picture reverses in certain groups. A meta-analysis focused specifically on older adults found that peritoneal dialysis carried a 17% higher mortality risk than hemodialysis overall in that population, with the gap widening for patients with diabetes, those with more comorbidities, and those who had been on dialysis for more than three years.9PubMed Central. Mortality of Peritoneal Dialysis versus Hemodialysis in Older Adults: An Updated Systematic Review and Meta-Analysis So the short version is that peritoneal dialysis looks favorable early on and for younger, healthier patients, while hemodialysis may be the better bet for older adults with significant health problems who need long-term treatment.
The Transplant Advantage
A kidney transplant is the treatment most likely to extend life in stage 5 kidney failure, and the size of the benefit is substantial. One study using target-trial emulation methods found that transplant recipients gained about half a year of additional survival over five years of follow-up and about 2.4 additional years over ten years, compared with patients who remained on the waiting list.10JAMA Network Open. Survival Benefit of First Single-Organ Deceased Donor Kidney Transplantation Compared With Long-term Dialysis Across Ages in Transplant-Eligible Patients With Kidney Failure An Australian analysis found that even patients with advanced age or coexisting conditions gained between six months and more than three extra years of life from transplantation compared to staying on dialysis.11PLOS ONE. Comparative Survival and Economic Benefits of Deceased Donor Kidney Transplantation and Dialysis in People with Varying Ages and Co-Morbidities
An interesting finding from a population-based cohort study is that the relative survival benefit of transplantation is actually greatest for high-risk patients, those over 65 or with significant comorbidities. Younger, healthier individuals already do reasonably well on dialysis, so transplantation does not add as many years in relative terms. This has led researchers to argue that age and comorbidities should not be considered reasons to exclude someone from transplant consideration, but rather strong indications for early transplantation.12PubMed Central. Life expectancy after kidney transplantation in a population-based retrospective cohort Of course, not everyone is eligible. Organ supply is limited, and some patients are too frail for transplant surgery. But for those who can receive one, the survival math is clearly favorable.
What Shortens or Lengthens Survival
The single biggest predictor of how long someone lives with stage 5 kidney failure is what other diseases they have, especially heart failure and diabetes. A 20-year population study found that among people with both heart failure and type 2 diabetes, median survival dropped to just 0.7 years once they reached stage 5 kidney disease. By contrast, patients with heart failure but without diabetes or kidney disease had a median survival of 4.4 years.13EClinicalMedicine. Trends in-hospitalisations and mortality in people with new-onset heart failure associated with type 2 diabetes and chronic kidney disease: a 20-year observational population-based study That specific combination of heart failure plus diabetes plus stage 5 kidney disease represents one of the worst prognostic profiles in medicine.
Beyond comorbidities, there is good evidence that preserving whatever kidney function remains, even a small amount, matters for survival on dialysis. This residual kidney function helps regulate fluid balance, clears toxins the dialysis machine misses, and reduces inflammation. Studies of peritoneal dialysis patients have found that maintaining residual kidney function is independently associated with longer survival, better nutritional status, and fewer infections.14PubMed. Prescribing high-quality peritoneal dialysis: The role of preserving residual kidney function 15PubMed Central. Preserving residual kidney function in peritoneal dialysis: from conventional approaches to contemporary practice Certain medications, particularly some blood pressure drugs, can help protect this remaining function, while others (like some anti-inflammatory drugs) can accelerate its loss. This is one reason nephrologists carefully manage medication lists for dialysis patients.
Quality of Life and the Conservative Path
Survival numbers only tell part of the story. A central question for many patients, especially older ones, is whether the extra time gained from dialysis is time well spent. Dialysis is grueling. Hemodialysis typically requires three sessions per week, each lasting several hours, and many patients feel drained for hours afterward. The time commitment alone reshapes daily life.
Research comparing quality of life between dialysis and conservative management in older adults has produced somewhat surprising findings. Conservative management provided comparable or, in some measures, superior quality of life and was associated with fewer hospitalizations.16PubMed Central. Dialysis versus conservative kidney management in older adults: why one size does not fit all A longitudinal study following elderly patients found that quality of life did not significantly improve after starting dialysis, while conservative-management patients experienced a small decline. But the dialysis group had a much higher hospitalization rate: about 50% were hospitalized within six months, versus 24% of conservative patients.17PubMed Central. Quality of life after the initiation of dialysis or maximal conservative management in elderly patients: a longitudinal analysis of the Geriatric assessment in OLder patients starting Dialysis (GOLD) study Patients managed conservatively still carry a high symptom burden, including fatigue, pain, and nausea, which is why the systematic review of conservative management emphasized the need for concurrent palliative care.1PubMed Central. Conservative Management of End-Stage Renal Disease without Dialysis: A Systematic Review
Palliative care in this context does not mean giving up on treatment. It means addressing pain, managing symptoms, and planning for what comes next. Palliative care consultation has been linked to better end-of-life outcomes, including higher rates of advance care planning and hospice referral.18PubMed. Association between Palliative Care Consultation and Advance Palliative Care Rates: A Descriptive Cohort Study in Patients at Various Stages in the Continuum of Chronic Kidney Disease Specialists in kidney palliative care can manage pain for dialysis patients too, not just those who have declined treatment, and effective pain management can reduce the overall symptom burden for people living on dialysis.19PubMed Central. The Significance of Palliative Care in Managing Pain for Patients Undergoing Hemodialysis
What Happens When Someone Stops Dialysis
Withdrawal from dialysis is more common than many people realize. It is one of the leading causes of death among dialysis patients, and it is especially frequent among those over 60. Understanding the timeline matters for families facing this decision.
After stopping dialysis, survival is typically measured in days, not weeks. A study of nearly 2,000 patients who discontinued dialysis and enrolled in hospice found mean survival of about 7 days, with a range of 0 to 40 days.20PubMed Central. Survival after dialysis discontinuation and hospice enrollment for ESRD A more recent study found median survival of about 6 days for hemodialysis patients and 4 days for peritoneal dialysis patients after their last treatment.21Kidney International Reports. Prognostication After Dialysis Withdrawal A Japanese study of hemodialysis patients aged 80 and older who withdrew found a slightly longer median of 10 days from last treatment to death.22PubMed Central. Factors Associated With Withdrawal From Dialysis Therapy in Incident Hemodialysis Patients Aged 80 Years or Older
Several factors affect how long a person survives after stopping. Those who still produce some urine tend to live longer, because their kidneys are still doing a small amount of filtering. The reason for stopping also matters: patients who withdrew for psychosocial reasons (such as deciding they no longer wanted to endure treatment) survived longer than those who withdrew because of acute medical deterioration. Serum sodium levels and smoking status were also associated with post-withdrawal survival time in one study.21Kidney International Reports. Prognostication After Dialysis Withdrawal Families should know that this period can be managed with comfort-focused care: hospice teams experienced with kidney failure can control fluid overload symptoms, shortness of breath, and restlessness effectively.
Children With Stage 5 Kidney Failure
The picture is very different for children. Pediatric kidney failure is far less common than in adults, but the stakes are uniquely high because these patients face a lifetime of treatment. A landmark study in the New England Journal of Medicine found that long-term survival for children requiring kidney replacement therapy was 79% at 10 years and 66% at 20 years. Even so, mortality rates were 30 times higher than for children without kidney failure.23PubMed. Long-term survival of children with end-stage renal disease The youngest children, especially infants under one year old, faced the highest risk, with death rates about four times those of teenagers. Children on dialysis had more than four times the mortality risk compared to those who received a transplant, which is why pediatric nephrologists push aggressively for transplantation whenever possible.
A binational cohort study looking at life-years lost found that children with kidney failure lose between 16 and 32 years of life expectancy compared to the general population. The loss was greatest among girls and those who developed kidney failure at the youngest ages. More of their remaining life years were spent on dialysis than with a functioning transplant, highlighting the gap between transplant availability and need.24PubMed Central. Life Years Lost in Children with Kidney Failure: A Binational Cohort Study with Multistate Probabilities of Death and Life Expectancy
Racial and Geographic Patterns in Survival
Kidney failure is not distributed equally, and neither is survival once it develops. In the United States, racial and ethnic minorities are more likely to reach stage 5 kidney disease than white Americans, even though the prevalence of earlier stages of kidney disease is similar across groups.25PubMed Central. Racial disparities in kidney disease outcomes Paradoxically, once on dialysis, Black patients tend to have better survival than white patients. One explanation is a form of survivorship bias: Black individuals face higher mortality in earlier stages of kidney disease, so those who reach stage 5 may represent a comparatively resilient subset of the population.26PubMed Central. Racial differences in mortality among those with CKD
Geography also plays a role. A multinational study found that dialysis mortality rates across countries track closely with that country’s background rates of cardiovascular disease in the general population. Eastern European countries, where cardiovascular death rates are higher in general, also had higher dialysis mortality, while Southeast and East Asian countries with lower cardiovascular death rates in the general population also had lower dialysis mortality.27Journal of the American Society of Nephrology. International Differences in Dialysis Mortality Reflect Background General Population Atherosclerotic Cardiovascular Mortality This suggests that a substantial portion of what determines dialysis survival has nothing to do with the dialysis itself and everything to do with the patient’s underlying cardiovascular health, shaped in part by diet, genetics, healthcare access, and lifestyle patterns that vary by region.
Why Early Referral Matters
One of the most actionable findings in the kidney failure literature is that getting to a nephrologist earlier makes a measurable difference in how long someone lives. An updated meta-analysis found that patients referred early to nephrologists had about a 33% lower risk of dying from any cause compared to those referred late. The survival advantage appeared as early as six months after starting dialysis and persisted through the fifth year.28PubMed Central. Early versus late nephrology referral and patient outcomes in chronic kidney disease: an updated systematic review and meta-analysis A separate study confirmed that early referral improved long-term survival and reduced hospitalizations after dialysis initiation, independent of whether the patient started dialysis under ideal circumstances.29PubMed Central. Early referral to nephrological care improves long-term survival and hospitalization after dialysis initiation, independent of optimal dialysis start – a call for harmonization of reimbursement policies
Early referral helps for several practical reasons. It gives the medical team time to prepare a dialysis access site (the surgically created connection used for hemodialysis) months before it is needed, avoiding the emergency catheters that carry higher infection risk. It allows time to discuss all the options, including peritoneal dialysis, transplant evaluation, and conservative management, rather than making rushed decisions during a crisis. And it lets patients begin managing their blood pressure, anemia, and mineral balance earlier, which slows the damage kidney failure does to the heart and bones. A systematic review of prognostic models for kidney failure patients noted that existing mortality prediction tools are limited by high risk of bias and poor real-world applicability, which makes the clinician-patient relationship built through early referral all the more important for individualized decision-making.30PubMed Central. Mortality Risk Prediction Models for People With Kidney Failure